Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review
about
PEGylation of Interferon-β-1aMajor clinical research advances in gynecologic cancer in 2010Use of pegylated liposomal doxorubicin in the management of platinum-sensitive recurrent ovarian cancer: current concepts.Carboplatin hypersensitivity: evaluation and successful desensitization protocol.The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer.
P2860
Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Tolerability, efficacy, and sa ...... an cancer: a systematic review
@ast
Tolerability, efficacy, and sa ...... an cancer: a systematic review
@en
type
label
Tolerability, efficacy, and sa ...... an cancer: a systematic review
@ast
Tolerability, efficacy, and sa ...... an cancer: a systematic review
@en
prefLabel
Tolerability, efficacy, and sa ...... an cancer: a systematic review
@ast
Tolerability, efficacy, and sa ...... an cancer: a systematic review
@en
P2093
P2860
P1433
P1476
Tolerability, efficacy, and sa ...... an cancer: a systematic review
@en
P2093
Edward C Grendys
Francis Vekeman
Patrick Lefebvre
Robert W Holloway
Scott McMeekin
P2860
P304
P356
10.1634/THEONCOLOGIST.2009-0331
P577
2010-10-07T00:00:00Z